Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Clin Chim Acta ; 456: 122-127, 2016 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-26820766

RESUMEN

BACKGROUND: Craniometaphyseal dysplasia (CMD) is a rare genetic disorder that is characterized by progressive sclerosis of the craniofacial bones and metaphyseal widening of long bones, and biochemical indexes were mostly normal. To further the understanding of the disease from a biochemical perspective, we reported a CMD case with obviously abnormal biochemical indexes. CASE REPORT: A 1-year-old boy was referred to our clinic. Biochemical test showed obviously increased alkaline phosphatase (ALP) and parathyroid hormone (PTH), mild hypocalcemia and hypophosphatemia. Moreover, significant elevated receptor activator of nuclear factor kappa-B ligand (RANKL) level, but normal ß-C-terminal telopeptide of type I collagen (ß-CTX) concentration were revealed. He was initially suspected of rickets, because the radiological examination also showed broadened epiphysis in his long bones. Supplementation with calcium and calcitriol alleviated biochemical abnormality. However, the patient gradually developed osteosclerosis which was inconformity with rickets. Considering that he was also presented with facial paralysis and nasal obstruction symptom, the diagnosis of craniometaphyseal dysplasia was suspected, and then was confirmed by the mutation analysis of ANKH of the proband and his family, which showed a de novo heterozygous mutation (C1124-1126delCCT) on exon 9. CONCLUSIONS: Our study revealed that obvious biochemical abnormality and rickets-like features might present as uncommon characteristics in CMD patients, and the calcium and calcitriol supplementation could alleviate biochemical abnormalities. Furthermore, although early osteoclast differentiation factor was excited in CMD patient, activity of osteoclast was still inert.


Asunto(s)
Enfermedades del Desarrollo Óseo/complicaciones , Enfermedades del Desarrollo Óseo/metabolismo , Anomalías Craneofaciales/complicaciones , Anomalías Craneofaciales/metabolismo , Hiperostosis/complicaciones , Hiperostosis/metabolismo , Hipertelorismo/complicaciones , Hipertelorismo/metabolismo , Raquitismo/complicaciones , Fosfatasa Alcalina/metabolismo , Enfermedades del Desarrollo Óseo/genética , Anomalías Craneofaciales/genética , Exones/genética , Femenino , Heterocigoto , Humanos , Hiperostosis/genética , Hipertelorismo/genética , Hipocalcemia/complicaciones , Hipofosfatemia/complicaciones , Lactante , Masculino , Mutación , Hormona Paratiroidea/metabolismo , Linaje , Proteínas de Transporte de Fosfato/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA